ABCB6 and diffuse large B-cell lymphoma: Inhibition of this pathway using either a dominant active form of NF-κB inhibitory protein inhibitor of kappa B (IκB)-α or a specific IκB kinase inhibitor is toxic to ABC- but not to GCB-DLBCL cell lines [59, 100].